|
Volumn 35, Issue 8, 2003, Pages 2878-2880
|
Triple immunosuppression with or without basiliximab in pediatric renal transplantation: Acute rejection rates at one year
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AZATHIOPRINE;
BASILIXIMAB;
CALCINEURIN INHIBITOR;
CYCLOSPORIN;
IMMUNOSUPPRESSIVE AGENT;
LIVER ENZYME;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PREDNISOLONE;
TACROLIMUS;
ACUTE GRAFT REJECTION;
ADOLESCENT;
ARTICLE;
CADAVER DONOR;
CHRONIC GRAFT REJECTION;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DIARRHEA;
DRUG EFFECT;
DRUG SAFETY;
DRUG TOLERABILITY;
FACIAL NERVE PARALYSIS;
FEMALE;
GINGIVA HYPERTROPHY;
GLOMERULUS FILTRATION RATE;
GRAFT SURVIVAL;
HUMAN;
HYPERTRICHOSIS;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY BIOPSY;
KIDNEY GRAFT REJECTION;
KIDNEY TRANSPLANTATION;
KIDNEY TUBULE DISORDER;
LIVER LEVEL;
LIVING DONOR;
MALE;
NEUTROPENIA;
PEDIATRIC SURGERY;
POSTOPERATIVE COMPLICATION;
POSTOPERATIVE PERIOD;
PRIORITY JOURNAL;
SCHOOL CHILD;
SIDE EFFECT;
STATISTICAL SIGNIFICANCE;
SURVIVAL RATE;
TREATMENT OUTCOME;
|
EID: 0345870172
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2003.10.087 Document Type: Article |
Times cited : (18)
|
References (7)
|